Image guided surgery for the resection of brain tumours

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 1, 2014, Pages

  Barone, Damiano Giuseppe ^a   Lawrie, Theresa A ^b   Hart, Michael G ^c  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DIAGNOSTIC AGENT;

BRAIN METASTASIS; BRAIN TUMOR; CANCER SURGERY; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION TENSOR IMAGING; ECHOGRAPHY; EDEMA; FLUORESCENCE IMAGING; FOLLOW UP; GLIOMA; HEMATOMA; HISTOPATHOLOGY; HUMAN; IMAGE DISPLAY; INTERPERSONAL COMMUNICATION; INTERVENTION STUDY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; LIQUORRHEA; LONG TERM CARE; MENINGIOMA; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; SKULL BASE TUMOR; SURGICAL INFECTION; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; WOUND COMPLICATION; COMPUTER ASSISTED SURGERY; METHODOLOGY;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; NEURONAVIGATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGERY, COMPUTER-ASSISTED;

EID: 84894298089     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009685.pub2     Document Type: Review

References (54)

1. Senft C, Bink A, Franz K, Gasser T, Seifert V. Intra-operative MRI-Guided vs. conventional microsurgical brain tumor resection - results of a prospective randomized trial. Journal of Neurosurgery 2011;115:Abstract number 602.
2. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncology 2011;12:997-1003.
3. Senft C, Bink A, Heckelmann M, Gasser T, Seifert V. Glioma extent of resection and ultra-low-field ioMRI: interim analysis of a prospective randomized controlled trial. Acta Neurochirurgica Supplementum 2011;109:49-53.
4. Pichelmeier U, Bink A, Schackert G, Stummer W, ALA Glioma Study Group. Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients. Neuro-oncology 2008;10(6):1025-34.
5. Stummer W, Pichelmeier U, Meinel T, Wiestler OD, Zenella F, Reulen H-J, ALA-Glioma Study Group*. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III. trial. Lancet Oncology 2006;7:392-401.
6. Stummer W, Reulen H-J, Meinel T, Pichelmeier U, Schumacher W, Tonn J-C, et al. ALA-Glioma Study Group*. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62:564-76.
7. Stummer W, Tonn J-C, Mehdorn HM, Nestler U, Franz K, Goetz C, Bink A, Pichlmeier U, ALA-Glioma study group*. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Journal of Neurosurgery 2011;114(3):613-23.
8. Willems PW, Taphoorn MJ, Burger H, Berkelbach van der Sprenkel JW, Tulleken CA. Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. Journal of Neurosurgery 2006;104:360-8.
9. Wu JS, Zhou LF, Tang WJ, Mao Y, Hu J, Song YY, et al. Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts. Neurosurgery 2007 Nov;61(5):935-49.
10. Bergsneider M, et al. Mahaley Clinical Research Award: extent of glioma resection using low-field (0.2 T) versus high-field (1.5 T) intraoperative MRI and image-guided frameless neuronavigation. Clinical Neurosurgery 2005;52:389-99.
11. Eljamel M, Goodman C, Moseley H. ALA and Photofrin® Fluorescence guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III. randomised controlled trial. Lasers in Medical Science 2008;23(4):361-7.
12. Koc K, et al. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. British Journal of Neurosurgery 2008;22(1):99-103.
13. Rohde V, Coenen VA. Intraoperative 3-Dimensional Ultrasound for Resection Control During Brain Tumour Removal: Preliminary Results of a Prospective Randomized Study. In: Pamir MN, V. Seifert V, Kiris T editor(s). Intraoperative Imaging. Springer Vienna, 2011:187-90.
14. Wirtz CR, et al. The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurological Research 2000;22(4):354-60.
15. Wu JS, et al. Role of diffusion tensor imaging in neuronavigation surgery of brain tumors involving pyramidal tracts. Zhonghua Wai Ke Za Zhi 2003;41(9):662-6.
16. Wu JS, et al. Integrating functional magnetic resonance imaging in neuronavigation surgery of brain tumors involving motor cortex. Zhonghua Yi Xue Za Zhi 2004;84(8):632-6.
17. Sloan A. Imaging procedure using ALA in finding residual tumor in grade IV malignant astrocytoma. ClinicalTrials.gov 2008.
18. Kubben PL. Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors. ClinicalTrials.gov February 2010.
19. Kanner A. Comparison of Neuro-navigational Systems for Resection-Control of Brain Tumors. ClinicalTrials.gov August 2009.
20. Zhou L-F, Mao Y, Wu J-S. iMRI Guided Resection in Cerebral Glioma Surgery. ClinicalTrials.gov November 2011.
21. Honea N. Fluorescence-guided Surgery for Low- and High-grade Gliomas. ClinicalTrials.gov December 2011.
22. Senft C. Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery (IMAGER). ClinicalTrials.gov February 2013.
23. Black PM, Moriarty T, Alexander E 3rd, Stieg P, Woodard EJ, Gleason PL, et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery 1997;41(4):831-42.
24. Centre for Reviews and Dissemintation. Systematic Reviews: CRD's guidance for undertaking reviews in health care. York: York Publishing Services Limited. www.york.ac.uk/inst/crd 2008.
25. Deeks JJ, Altman DG, Bradburn MJ. Systematic Review in HealthCare: Meta-analysis in Context. In: Egger M, Davey Smith G, Altman DG editor(s). Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. 2nd Edition. London: BMJ Publication Group, 2001.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
27. Fowkes FGR, Fulton PM. Critical appraisal of published research: introductory guidelines. BMJ 1991;302:1136-40.
28. Chang S, Vogelbaum M, Lang FF, Haines S, Kunwar S, Chiocca EA, et al. GNOSIS: guidelines for neuro-oncology: standards for investigational studies - reporting of surgically based therapeutic clinical trials. Journal of Neuro-Oncology 2007;82:211-20.
29. Hart MG, Grant R, Metcalfe SE. Biopsy versus resection for high grade glioma. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD002034]
30. Hensen JW, Ulmer S, Harris GJ. Brain tumor imaging in clinical trials. American Journal of Neuroradiology 2008;24(3):419-24.
31. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
32. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
33. Karnofksy DA. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-56.
34. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007 Aug;114(2):97-109.
35. Mauer ME, Bottomley A, Taphoorn MJB. Evaluating health- related quality of life and symptom burden in brain tumour patients: instruments for use in clinical trials and clinical practice. Current Opinion in Neurology 2008;21:741-53.
36. Medical Dictionary for Regulatory Authorities (MedDRA). http://www.meddramsso.com/MSSOWeb/index.htm 2008.
37. Miwa K, Shinoda J, Yano H, Okumura A, Iwama T, Nakashima T, Sakai N. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study. Journal of Neurology, Neurosurgery and Psychiatry 2004;75:1457-62.
38. National Collaborating Centre for Cancer. Improving outcomes for people with brain and other CNS tumours - evidence review. http://www.nice.org.uk/nicemedia/live/10905/28965/28965.pdf.
39. NIH Stroke Scale. National Institute for Health Stroke Scale (NIHSS). http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf.
40. Ohgaki H. Epidemiology of brain tumors. Methods in Molecular Biology 2009;472:323-42.
41. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature of endpoints. Statistics in Medicine 1998;17:2815-34.
42. Pichelmeier U, Bink A, Schackert G, Stummer W, ALA Glioma Study Group. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro-oncology 2008;10:1025-34.
43. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, et al. Updated response assessment criteria for high grade gliomas: response assessment in neuro-oncology working group. Journal of Clinical Oncology 2010;28(11):1963-72.
44. Regula J, MacRobert AJ, Gorchein A, Buonaccorsi GA, Thorpe SM, Spencer GM, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut 1995;36:67-75.
45. Sanai N, Berger MS. Operative techniques for gliomas and the value of extent of resection. Neurotherapeutics 2009;6:478-86.
46. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical outcomes in a modem series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998;42:1044-1056.
47. Seifert V. Intraoperative MRI in neurosurgery: Technical overkill or the future of brain surgery?. Neurology India 2003;51:329-32.
48. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 1998;42:518-25.
49. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guidedresection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. Journal of Neurosurgery 2000;93:1003-13.
50. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine 2005;352:987-96.
51. Unsgaard G, Rygh OM, Selbekk T, Müller TB, Kolstad F, Lindseth F, et al. Intra-operative 3D ultrasound in neurosurgery. Acta Neurochirurgica 2006 Mar;148(3):235-53.
52. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria in high grade gliomas: response assessment in neuro-oncology working group. Journal of Clinical Oncology 2010;28(11):1963-72.
53. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 1982;5:649-55.
54. Yordanova YN, Moritz-Gasser S, Duffau H. Awake surgery for WHO Grade II. gliomas within "non-eloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Journal of Neurosurgery 2011;115(2):232-9.